Cardiac anaplastic large cell lymphoma in an 8-year old boy
- PMID: 24918065
- PMCID: PMC4050286
- DOI: 10.1016/j.lrr.2014.05.001
Cardiac anaplastic large cell lymphoma in an 8-year old boy
Abstract
We report on an 8 year old boy with primary cardiac anaplastic large cell lymphoma (ALCL), in whom the diagnosis was challenging and who was treated with modified chemotherapy without radiation therapy according to the ALCL 99 study protocol [1]. Two years and 4 months after completion of therapy the boy is in complete remission with normal cardiac function.
Keywords: ALCL; ALCL99; Cardiac tumour; Childhood; Heart; Lymphoma.
Figures
References
-
- Brugieres L, Le Deley MC, Rosolen A, Williams D, Horibe K, Wrobel G. Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group. J Clin Oncol. 2009;27:897–903. - PubMed
-
- Damm-Welk C, Klapper W, Oschlies I, Gesk S, Rottgers S, Bradtke J. Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation. Br J Haematol. 2009;146:306–309. - PubMed
-
- Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin–Frankfurt–Munster group trial NHL-BFM 90. Blood. 2001;97:3699–3706. - PubMed
-
- Lim ZY, Grace R, Salisbury JR, Creamer D, Jayaprakasam A, Ho AY. Cardiac presentation of ALK positive anaplastic large cell lymphoma. Eur J Haematol. 2005;75:511–514. - PubMed